SRINAGAR: Authorities at the Shri Maharaja Hari Singh (SMHS) Hospital have failed to procure the essential blood clotting factor for at least 250 hemophilia patients, even as the J&K Medical Supplies Corporation Ltd (JKMSCL) gave them the go-ahead for local purchase.
Official sources told Kashmir Reader that SMHS Hospital officials didn’t purchase the emergency blood product, Factor VIII, despite a No Objection Certificate (NOC) obtained last month from the JKMSCL.
“The Corporation has already given them NOC for getting the blood component through local purchase. But the hospital couldn’t purchase the Factor VIII because distributors are refusing them fresh supply as officials are yet to clear their dues,” the sources said.
The Hemophilia Daycare Centre at the hospital has been running out of Factor VIII stock for the whole of last year as there was no rate contract available with the JKMSCL. After patients and their families raised a hue and cry, the SMHS Hospital was asked by the government to purchase the blood component locally.
However the process is delayed due to lack of funds for the blood factor.
“No funds have been released so far by the Government Medical College, Srinagar,” said an official.
Sources said that hemophilia patients are facing a life threat because the Hemophilia Daycare Centre is without blood factors.
“People accompanying critical patients are forced to buy blood factors from the open market which costs them dearly. The hospital always faces a shortage of Factor VIII, which has a huge requirement of more than 30 vials per day costing nearly Rs 4 crore per year for 10,800 vials,” they said.
Nearly two lakh vials are required for the full course for each patient. “Only a meagre amount is presently available with the SMHS Hospital,” said a doctor.
The SMHS Hospital Medical Superintendent Dr Saleem Tak told Kashmir Reader that the Factor VIII would be purchased soon.
“Principal GMC Srinagar has already released nearly Rs 60 lakh for hemophilia patients this week. We are now looking for distributors who will provide us the Factor VIII,” he said.